Nordics biotech and pharma directory

Kuopio digital-health medtech startup building wearable sensor and surface EMG analytics for Parkinson's disease and movement-disorder symptom quantification, CE-marked medical device and a Gerresheimer partnership.

Lead

PCPaulus CarpelanChief Executive Officer and Co-Founder

Scale

Medical-device and digital health delivery

Copenhagen clinical-stage antibody-drug conjugate biotech with a first- and best-in-class pipeline led by ADCE-D01, a uPARAP-targeted ADC with FDA Fast Track designation for soft-tissue sarcoma.

Lead

MPMichael PehlChief Executive Officer

Scale

Clinical-stage ADC development

Oslo molecular diagnostics startup developing DNA methylation and epigenetic biomarker tests for age-related diseases, with a lead candidate targeting early-stage rheumatoid arthritis diagnosis.

Lead

ALAndre LovestamChief Executive Officer

Scale

Molecular diagnostics development

Sandvika alginate-chemistry biotech developing OligoG CF-5/20, a low-G alginate oligomer in Phase 2b for cystic fibrosis mucus clearance and biofilm disruption, with EU Horizon 2020 and Cystic Fibrosis Foundation grant support.

Lead

YPYngvar P. BergChief Executive Officer

Scale

Clinical-stage alginate oligomer development

Norwegian life-science tools distributor focused on antibody catalog sales (more than 30,000 SKU), lab shakers and incubators, COVID-19 antigen tests, and aquaculture pathogen diagnostics for the salmon industry.

Lead

HWHuahong WangGeneral Manager

Scale

Distributor and reseller operations

Kuopio preclinical-stage pharma SME developing non-steroidal small-molecule androgen-receptor inhibitors for topical hair loss and acne treatments, with GLP safety studies via partners.

Lead

MKMika KayhkoChief Executive Officer

Scale

Preclinical small-molecule development

Orsta-based marine-lipid pharma and nutraceutical company developing HRO350, a herring-roe-derived Phase IIb candidate for mild-to-moderate psoriasis, alongside the commercial Romega omega-3 phospholipid brand.

Lead

CLChrister L. ValderhaugChief Executive Officer

Scale

GMP clinical and commercial nutraceutical supply

Kuopio clinical-stage live-biotherapeutic company engineering lactic-acid bacteria to secrete therapeutic proteins, with lead candidate AUP-16 in Phase 1 for diabetic foot ulcers; group headquarters in Schlieren, Switzerland.

Lead

JYJuha YrjanheikkiChief Executive Officer and Co-Founder

Scale

Clinical-stage live-biotherapeutic development

Turku pharmaceutical manufacturing site producing hormonal IUDs (Mirena, Kyleena, Jaydess) for Bayer's global contraceptive portfolio, with a disclosed 250 million EUR automated plant expansion opened in 2025.

Lead

TPTomi PenttilaHead of Bayer Product Supply Center, Turku

Scale

Commercial specialty pharmaceutical manufacturing

Kuopio medical-device company developing the Bindex point-of-care pulse-echo ultrasound for osteoporosis diagnosis, FDA 510(k)-cleared and CE-marked.

Lead

JKJanne KarjalainenChief Executive Officer

Scale

Medical-device manufacturing

Oslo clinical-stage antibody biotech targeting fibrosis and inflammation through the first-in-class anti-S100A4/S100A9 antibody CAL101, with Phase 1 completed in October 2024 and backing from Forbion.

Lead

MGMark GaffneyChief Executive Officer

Scale

Clinical-stage antibody development

Trondheim certified-reference-standard manufacturer (since 1983) supplying catalog and custom synthesis reference materials for toxicology, environmental, food safety, pharmaceutical, petroleum, and geochemistry analytical labs; part of Antylia Scientific / ZeptoMetrix since 2024.

Lead

JJJon JohansenChief Executive Officer and Research Director

Scale

Custom microgram to kilogram reference materials

Pre-clinical regenerative-medicine startup building vascularized, cell-synthesized extracellular-matrix implants via the CLEX hydrogel scaffold and VivoSet platform, with early applications in Type-1 diabetes, liver, and heart disease.

Lead

AGArmend G. HatiChief Executive Officer and Co-Founder

Scale

Pre-clinical tissue engineering

Aarhus preclinical biotech building complement-powered immune-engager biologics through the BiCE Complement Engager platform, with a 2025 non-human primate proof-of-concept milestone and a newly named CEO from March 2026.

Lead

TLThomas L. F. Montgomery AndresenChief Executive Officer

Scale

Preclinical biotech development

Privately held Lund developer of humanized anti-PSA and anti-hK2 antibodies for radiolabeled theranostic programs in prostate cancer, licensed in part to Radiopharm Theranostics.

Lead

JDJohan DrottFounder and Chief Executive Officer

Scale

Preclinical to early-clinical, partner-led

Copenhagen gene-therapy platform biotech developing a cell-free viral vector manufacturing system for scalable AAV production, with pre-seed backing from HCVC and BII and an active R&D site in Leiden, Netherlands.

Lead

JTJordan TurnbullCo-Chief Executive Officer and Co-Founder

Scale

Platform R&D to early process demonstration

Nasdaq-listed clinical-stage biotech (GLTO) with Copenhagen operating headquarters, developing small-molecule galectin-3 and LOXL2 inhibitors for fibrosis, oncology, and inflammation.

Lead

HSHans SchambyeChief Executive Officer

Scale

Clinical-stage small-molecule development

Norway's largest pharmaceutical manufacturing site, producing bulk iohexol and iodixanol API for GE HealthCare's global iodinated contrast-media business from a 100-acre integrated chemical campus operating since 1974.

Lead

PJPeter J. ArduiniPresident and CEO, GE HealthCare Technologies (global)

Scale

Bulk API manufacturing for global contrast-media supply

Copenhagen glycomics IVD startup building AI-augmented GlycA and GlycB-class biomarker tests for neurodegenerative and autoimmune disease diagnostics and monitoring.

Lead

BDBrian DellavalleChief Executive Officer and Founder

Scale

Diagnostics platform development

Copenhagen clinical-stage neuroscience biotech developing non-opioid chronic neuropathic pain and sensorineural hearing loss therapeutics, with lead candidate HB-086 targeting the peripheral nervous system.

Lead

TMTorsten M. MadsenChief Executive Officer

Scale

Early clinical-stage biotech

Umea preclinical CRO built around the proprietary NIF mouse model, supplying in vivo efficacy readouts for anti-fibrotic and anti-inflammatory drug candidates across liver and kidney programs.

Lead

SMSofia MayansCo-Founder and Chief Executive Officer

Scale

Preclinical contract research

Kuopio ATMP CDMO providing Fimea-authorized GMP viral-vector manufacturing (AAV, adenovirus, lentivirus) for gene and cell therapy programs, owned by Ferring Ventures since 2020.

Lead

TKTuija KekarainenScientific Director and Cell Therapy Unit Director

Scale

GMP viral-vector manufacturing

Aalborg methylation-diagnostics reagent company supplying methylation-sensitive high-resolution melting (MS-HRM) EpiMelt kits for research oncology assay development, with distribution through TATAA Biocenter and Boca Scientific.

Lead

TKTomasz K. WojdaczChief Executive Officer and Co-Founder

Scale

Research-use reagent manufacturing

Aarhus clinical-stage neuromuscular biotech developing ClC-1 chloride-channel inhibitors to restore muscle function, with lead candidate NMD670 in Phase 2 for myasthenia gravis.

Lead

THThomas Holm PedersenCo-Founder and Chief Executive Officer

Scale

Clinical-stage small-molecule development